ENTITY

Neurovive Pharmaceutical Ab (NVP SS)

Analysis

Health Care • Sweden

NeuroVive Pharmaceutical AB researches and develops drugs for the treatment of traumatic brain injuries. The Company produces nerve cell-protecting and cyclosporine-based pharmaceuticals.

Refresh

Exchange Announcement • 22 Nov 2022 20:00

Q3 2022

Exchange Announcement • 19 Aug 2022 19:18

Q2 2022

Exchange Announcement • 31 May 2022 19:18

Q1 2022

Exchange Announcement • 20 Feb 2022 20:18

Q4 2021

Exchange Announcement • 19 Nov 2021 08:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q3 2022

Q2 2022

Q1 2022

Q4 2021

Q3 2021